Every year in September, the HIV Cure Research Center organized a lively HIV-oriented symposium in the picturesque city of Ghent, Belgium. Since the pandemic outbreak of SARS-CoV-2 in 2020, the lab has also invested heavily in the initiation of key research in COVID-19. Therefore, for the second year in a row, we decided to organize an HIV and SARS-CoV-2 hybrid symposium, which will take place the 21nd of October. During this symposium we will discuss key aspects of SARS-CoV-2 pathogenesis and HIV cure.
We walk you through the basic principles of SARS-CoV-2 pathogenesis, pathophysiology and SARS-CoV-2 protection by vaccination. In addition, we focus on HIV reservoirs and cure.
The HIV and SARS-CoV-2 hybrid symposium will comprehensively summarize the state of the art in COVID-19 and HIV cure strategies.
CALL FOR ABSTRACTS
The HIV Cure Research Center invites you to submit abstracts for oral presentations for the HIV and SARS-CoV-2 Hybrid Symposium to be held on Thursday, October 21, 2021 at the Roularta Center, Zellik, Belgium or online. The length of abstracts for presentations should not exceed 350 words. Ten minutes will be foreseen for each oral presentation.
The deadline for abstract submission is September 10, 2021. Notification of acceptance will be made on September 24, 2021. Please send abstracts as Pdf document to Karen Vervisch, karen.vervisch@uzgent.be by September 10.
Program
| COVID-19 PATHOGENESIS - Chaired by Steven Callens & Guido Vanham | |
|---|---|
|
09.00 - 09.05 |
Welcome and Introduction Linos Vandekerckhove, Ghent University Hospital, Ghent, Belgium |
|
09.05 - 09.30 |
Lessons learned after 18 months SARS-CoV-2 pandemic Steven Van Gucht, Sciensano, Brussels, Belgium Q&A |
|
09.30 - 09.55 |
SARS-CoV-2 spread through the human body Jolien Van Cleemput, Ghent University, Ghent, Belgium Q&A |
|
09.55 - 10.20 |
Poster Session TBC Q&A |
|
10.20 - 10.45 |
Break and Posterviewing |
| COVID-19 VACCINATION - Chaired by Sarah Gerlo & Bert Schepens | |
|---|---|
|
10.45 - 11.10 |
Response of SARS-CoV-2 vaccination towards variants Steven Callens, Ghent University Hospital, Ghent, Belgium Q&A |
|
11.10 - 11.35 |
Antibody-based treatment for SARS-CoV-2 infection Delphine Acar, Ghent University, Ghent, Belgium Q&A |
|
11.35 - 12.00 |
Poster Session TBC Q&A |
|
12.00 - 13.00 |
Break/Satellite Symposia |
| HIV RESERVOIR - Chaired by Jozefien De Clerq & Marion Pardons | |
|---|---|
|
13.00 - 13.25 |
How to assess the micro environment of the HIV reservoir Jacob Estes, Oregon Health and Science University, Oregon, US Q&A |
|
13.25 - 13.50 |
Next generation multiplex assays for assessement of HIV intactness Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium Q&A |
|
13.50 - 14.15 |
Poster Session TBC Q&A |
|
14.15 - 14.30 |
Break and posterviewing |
| HIV CURE - Chaired by Wojciech Witkowski & Jolien Van Cleemput | |
|---|---|
|
14.30 - 14.55 |
Engineering the immune system for HIV Cure Paula Cannon, University of Southern California, California, US Q&A |
|
14.55 - 15.20 |
Current efforts towards a cure based on bNAb's Sarah Fidler, Imperial College London, London, UK Q&A |
|
15.20 - 15.45 |
Poster Session TBC Q&A |
|
15.45 - 16.00 |
Break |
|
16.00 - 16.15 |
Closing and voting results Linos Vandekerckhove, Ghent University and Ghent University Hospital, Ghent, Belgium |
Sponsored by:
WERELDWIJD LEVEN 37 MILJOEN MENSEN MET HIV. STEUN HET FONDS HIV ONTRAFELEN en Help hen.
Door de COVID-19 maatregelen zal de 7de editie pas in december 2021 plaatsvinden.
Doneren
-
Of via overschrijving:
Universiteitsfonds UGent - IBAN BE26 3900 9658 0329
- BIC BBRUBEBB
- Met duidelijke vermelding: HIVOntrafelen
- Giften vanaf 40 euro jaarsbasis zijn 60% fiscaal aftrekbaar in 2020 . Meer informatie: www.ugent.be/iksteunmee
Dutch 
English